Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Overall, PSMA-PET/CT detected distant metastasis in 84 of 182 cases (46%) that were negative by other types of imaging, ...

Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, prostate ...

Primarily used to screen for prostate cancer, PSA tests measure the level of prostate-specific antigen in the blood. “The ...

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.

Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation ...

Methods Patients, aged <68 yrs, with adenocarcinoma of the prostate (Gleason ≤ 7 ... and comparisons of tadalafil OaD and PRN versus placebo after OLT were not significant.

Q2 2025 Earnings Call Transcript January 8, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.04, ...

AngioDynamics' NanoKnife FDA clearance boosts its potential in cancer treatment. Read why ANGO stock is a buy with its growth ...

Stephen Trowbridge; Chief Financial Officer, Executive Vice President; AngioDynamics Inc Good morning and welcome to the AngioDynamics fiscal year 2025 second quarter earnings call at this time.